在肺腺癌中鉴定和免疫学特征的anoikis相关的分子
Shuyan He1, Xinru Xiao2, Chenglong Ma1
1Department of Tumor Center, The Affiliated Jiangyin Hospital of Nantong University, Jiangyin, Jiangsu, 214400, China.
Experimental cell research
|April 17, 2024
概括
安诺基斯是一种编程细胞死亡,影响肺腺癌 (LUAD) 的进展和免疫力. 这项研究确定了影响LUAD预后和免疫细胞透的阿诺基斯相关基因,有助于更好的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 阿诺基斯在肺腺癌 (LUAD) 进展,预后和免疫反应方面至关重要.
- 在LUAD病变发生过程中,无菌相关因素的确切作用尚不完全理解.
研究的目的:
- 为了研究在LUAD中化亡因子的作用.
- 识别影响LUAD预后和瘤微环境的瘤相关基因.
- 开发一个 LUAD 患者分层的预测模型.
主要方法:
- 在LUAD患者中分析了九个关键的嵌套性亡因子.
- 根据多元因素将患者分为两个不同的分子集群.
- 免疫细胞概况和群集之间的差异分析.
- 预后基因的识别和验证 (SLC2A1和SPHK1).
主要成果:
- 患者被分为两个群体,具有不同的免疫细胞透概况.
- 与B集群相比,A集群的先天性免疫细胞透率较高.
- 两种预后基因,SLC2A1和SPHK1,被确定并验证了它们在调节瘤细胞行为的作用.
- 开发了一个预测模型,以基于分子集区分患者.
结论:
- 特定的阿诺基斯相关基因的丢失显著影响LUAD预后,瘤微环境和临床特征.
- SLC2A1和SPHK1是LUAD中关键的预后基因,影响细胞活力,迁移,细胞亡和细胞衰老.
- 这项研究为未来的机制研究和改进的LUAD免疫疗法策略提供了洞察力.
更多相关视频
相关概念视频
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


